Cigna sues Bristol Myers over alleged monopoly for multiple myeloma drug Pomalyst

  • Cigna sued Bristol Myers on Tuesday, accusing the drugmaker of violating federal antitrust law by maintaining a monopoly over a blockbuster multiple myeloma drug sold under the brand name Pomalyst.